Lumivatamig Biosimilar – Research Grade from ProteoGenix; catalogue PX-TA2495; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The cutting-edge biotech product that is revolutionizing the field of biosimilars. This highly advanced research grade biosimilar is specifically designed to target and mimic the therapeutic effects of the well-known drug, Lumivatamig.
With its unique biological function, Lumivatamig Biosimilar – Research Grade offers researchers and scientists a powerful tool for studying and understanding the therapeutic mechanism of Lumivatamig. This biosimilar has been developed using state-of-the-art technology to closely replicate the structure and function of the original drug, ensuring accurate and reliable results.
Lumivatamig Biosimilar – Research Grade has a wide range of applications in the field of biotechnology. It can be used for in vitro studies, in vivo experiments, and as a reference standard for bioassays. This versatile biosimilar is suitable for a variety of research purposes, including drug discovery, drug development, and pharmacological studies.
One of the key benefits of Lumivatamig Biosimilar – Research Grade is its ability to target the same therapeutic target as the original drug. This makes it an ideal choice for researchers who are studying the effects of Lumivatamig on specific biological pathways or diseases. With its high level of similarity to the original drug, this biosimilar offers a reliable and accurate model for studying Lumivatamig’s therapeutic effects.
In addition, Lumivatamig Biosimilar – Research Grade has been extensively tested and validated in various experimental use cases. It has shown consistent and reproducible results, making it a trusted and reliable tool for researchers. Its high purity and quality also ensure minimal variability and maximum reproducibility in experiments.
In summary, Lumivatamig Biosimilar – Research Grade is a top-of-the-line biotech product that offers researchers a powerful tool for studying and understanding the therapeutic effects of Lumivatamig. Its unique biological function, wide range of applications, and proven reliability make it a valuable asset in the field of biosimilars. Don’t miss out on the opportunity to enhance your research with Lumivatamig Biosimilar – Research Grade. Order now and experience the next level of biosimilar technology.
ProteoGenix catalogue number PX-TA2495. For research use only.
Target: Lumivatamig Biosimilar – Research Grade; Host: Mammalian cells; Clonality: Monoclonal antibody; Expression system: Mammalian; Purity: >95% as determined by SDS-PAGE; Buffer: 0.01 M PBS pH 7.4.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
